DAN PUCKETT - 20 Mar 2023 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Chief Financial Officer
Signature
/s/ Wade Estey, as attorney-in-fact for Dan Puckett
Issuer symbol
N/A
Transactions as of
20 Mar 2023
Net transactions value
-$202,114
Form type
4
Filing time
22 Mar 2023, 21:17:17 UTC
Previous filing
23 Feb 2023
Next filing
19 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $18,700 +1,100 +3.3% $17.00* 34,758 20 Mar 2023 Direct F1
transaction SWAV Common Stock Sale $220,814 -1,100 -3.2% $200.74 33,658 20 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -1,100 -93% $0.000000 80 20 Mar 2023 Common Stock 1,100 $17.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022.
F2 All reported securities were sold at a price of $200.74.
F3 1/48th of the shares subject to the option shall vest monthly from 03/06/2019.